Pharmacy Daily | World-first for liver

Other recent headlines

• 

  Sigma’s share price rally

  Friday | Oct 4 2024

  SIGMA Healthcare Limited’s share price has surged this week, reaching $2.06, up from $1.46 seven days ago.

  
• 

  Oral drug for kids with T2D

  Friday | Oct 4 2024

  JARDIANCE (empagliflozin) has become the first oral treatment to be available on private script for type 2 diabetes (T2D) in children and adolescents, since metformin was indicated for use in this growing patient group.

  
• 

  Priceline’s rebrand “a real refresh”

  Thursday | Oct 3 2024

  PRICELINE is set to undergo a rebrand next month to reflect its strategy combining beauty with health expertise and value.